It overlapped with our consultations.
On May 2nd, 2023. See this statement in context.
On May 2nd, 2023. See this statement in context.
May 2nd, 2023 / 12:10 p.m.
Executive Director, Patented Medicine Prices Review Board
It overlapped with our consultations.
See context to find out what was said next.